Albumin-Globulin Ratio Is an Independent Prognostic Factor for Gastric Cancer Patients who Received Curative Treatment.

Autor: MOMOKO FUKUDA, TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, AYA KATO, KENTARO HARA, KEISUKE KAZAMA, KEISUKE KOMORI, AYAKO TAMAGAWA, HARUHIKO CHO, TETSUSHI ISHIGURO, KENKI SEGAMI, MASATO NAKAZONO, KAZUKI OTANI, SHO SAWAZAKI, MASAKATSU NUMATA, SHINNOSUKE KAWAHARA, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA
Předmět:
Zdroj: In Vivo; Mar/Apr2024, Vol. 38 Issue 2, p904-910, 7p
Abstrakt: Background/Aim: The albumin-globulin ratio (AGR) is a useful biomarker for predicting postoperative complications and a poor prognosis in patients with various types of cancer and can be evaluated without invasive testing or surgery. In this study, we aimed to evaluate the usefulness of the AGR in predicting the short- and long-term prognoses of patients with gastric cancer who underwent radical resection at our institution. Patients and Methods: This study is a retrospective cohort analysis in which eligible patients were selected from the medical records of patients who underwent radical resection for gastric cancer at Yokohama City University from 2000 to 2020 and their medical records were reviewed. A total of 240 patients with gastric cancer were classified into high-AGR (>1.57) and low-AGR (=1.57) groups and their overall survival (OS), recurrence-free survival (RFS), and postoperative complication rates were compared. Results: Of the total 240 patients, 87 were classified into the high AGR group and 153 were classified into the low AGR group; the incidence of postoperative complications in the two groups did not differ to a statistically significant extent (34.4% vs. 39.2%, p=0.491). The long-term findings showed that the 5-year OS and RFS rates were significantly better in the high AGR group [84.0% vs. 64.8% (p=0.005), 80.0% vs. 61.9% (p=0.015), respectively]. Conclusion: Preoperative low AGR is a risk factor for OS and DFS in patients with gastric cancer who undergo surgery. The AGR may be a useful biomarker that can be applied as a prognostic indicator for patients with gastric cancer. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index